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The Centers for Disease Control and Prevention (CDC) have announced a set of provisional
guidelines concerning male circumcision, in which they suggest that the benefits of the
surgery outweigh the risks. I offer a critique of the CDC position. Among other concerns,
I suggest that the CDC relies more heavily than is warranted on studies from Sub-Saharan
Africa that neither translate well to North American populations nor to circumcisions per-
formed before an age of sexual debut; that it employs an inadequate conception of risk in
its benefit vs. risk analysis; that it fails to consider the anatomy and functions of the penile
prepuce (i.e., the part of the penis that is removed by circumcision); that it underestimates
the adverse consequences associated with circumcision by focusing on short-term surgi-
cal complications rather than long-term harms; that it portrays both the risks and benefits
of circumcision in a misleading manner, thereby undermining the possibility of obtaining
informed consent; that it evinces a superficial and selective analysis of the literature on sex-
ual outcomes associated with circumcision; and that it gives less attention than is desirable
to ethical issues surrounding autonomy and bodily integrity. I conclude that circumcision
before an age of consent is not an appropriate health-promotion strategy.
Keywords: circumcision, Centers for Disease Control and Prevention, sexually transmitted diseases, HIV, autonomy,
medical ethics, benefit vs. risk, female genital mutilation
INTRODUCTION
The Centers for Disease Control and Prevention (CDC) have
announced a set of provisional guidelines concerning male cir-
cumcision, in which they suggest that the benefits of the surgery
outweigh the risks [(1), p. 2]. Although their main focus is on
the potential for male circumcision to provide partial protection
against female-to-male, heterosexually transmitted HIV, due to
the comparatively rare occurrence of such infections in the United
States, the CDC notes in its draft report that the “the overall public
health benefit [to] the entire U.S. population may be limited” [(2),
np]. Nevertheless, the proposed CDC guidelines have generated
significant interest among public health professionals, as well as
among the population at large. In this brief report, I highlight a
few of the key scientific and ethical issues worth considering in
interpreting these new recommendations.
FOLLOWING THE AAP
First, the CDC appears largely to be following the American
Academy of Pediatrics (AAP), whose 2012 policy statement and
technical report have already been subjected to numerous inter-
national critiques (3–12)1. While these critiques are not necessarily
1Note that replies and counter-replies to some of these critiques have been published.
For example, in response to an accusation of cultural bias by 38 senior physicians and
“representatives of general medical associations and societies for pediatrics, pedi-
atric surgery, and pediatric urology” from England, Canada, and Northern Europe
[(3), p. 796], the AAP argued that it is Europeans, not Americans, who are culturally
biased – only against circumcision rather than in favor of it (68). Offering a different
perspective, I have suggested elsewhere that: “By [implying that] a cultural norm
favoring the non-therapeutic, non-consensual surgical modification of a child’s
penis is somehow on par with, or just as reasonable as, a medical-ethical norm favor-
ing the avoidance of such surgery unless it is absolutely required, the AAP committee
simply reveals its cultural hand” [(69); for further discussion, see Ref. (12)].
definitive, it is worth noting that the CDC authors do not actu-
ally engage with them in their scientific discussion. Thus, they
fail adequately to address the concerns that have been raised in
these previous writings about the manner in which the AAP – and
by extension, the CDC – conducted its analysis of the available
literature on male circumcision, and presented its findings to
the public2.
Among other issues, critics have pointed out that the bulk
of the data used to justify the AAP/CDC policies was derived
from studies of adult circumcision carried out in sub-Saharan
Africa – a geographic region whose epidemiological environments
and patterns of disease transmission are dissimilar, along numer-
ous dimensions, to those elsewhere in the world (13–16). This is
important, because the spread of disease, including sexually trans-
mitted infections, is determined much more by socio-behavioral
and situational factors than by strictly anatomical-biological fac-
tors, such as the presence or absence of a foreskin (17, 18). In
other words, the apparent findings from these studies cannot be
simply mapped on to non-analogous public health environments
(15), nor to circumcisions performed earlier in life, i.e., before an
age of sexual debut (19). As Bossio et al. (20) argue in a recent
comprehensive review, not referenced by the CDC, “At present . . .
the majority of the literature on circumcision is based on research
that is not necessarily applicable to North American populations”
(p. 2847).
The CDC acknowledges this ‘translation’ problem: “Much of
the data related to HIV and STI prevention are from randomized
clinical trials (RCTs) conducted among men in sub-Saharan Africa
2See Earp (70), for a discussion of the proper role of scientific organizations in
shaping the public’s understanding of medicine.
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in regions with high rates of heterosexually acquired HIV infec-
tion. In the United States [by contrast], the prevalence of HIV and
lifetime risk of HIV infection are generally much lower than [in]
sub-Saharan Africa. Also, most new HIV infections in the United
States are attributed to male–male sex, a population for whom
male circumcision has not been proven to reduce the risk of HIV
acquisition” [(1), p. 1].
BENEFIT vs. RISK
In addition to such empirical limitations, the proposed CDC
guidelines exhibit conceptual and ethical limitations as well.
Conceptually, the CDC relies on an inappropriate construal of
risk in its benefit vs. risk analysis, since it appears to interpret
“risk” as referring (primarily or exclusively) to the “risk of surgi-
cal complications.” To begin with, the actual incidence of surgical
complications is not known, due to the poor quality of the available
data on this question as well as conflicting definitions of (and ways
of measuring)“complications”(21). Thus, as Garber (5) has noted,
“it is inconceivable that the AAP [and by extension, the CDC] could
have objectively concluded that the benefits of the procedure out-
weigh the risks when the ‘true incidence of complications’ isn’t
known” (p. 69). Nevertheless, it has been argued that the CDC
working group underestimated even the known risks of circum-
cision, by focusing on the comparatively rare, immediate surgical
risks and complications that occur soon after the operation, while
ignoring or downplaying the comparatively common intermedi-
ate and long-term complications, such as meatal stenosis, which
may require a surgical correction (22).
What if it could be shown, however, that the benefits of
circumcision did in fact outweigh the (overall) risk of surgi-
cal complications? Even so, the CDC test would still be ill-
conceived. This is because the standard heuristic for evaluating
non-therapeutic surgery (i.e., surgery performed in the absence
of disease or deformity) is not benefit vs. “risk of surgical com-
plications” but rather benefit vs. risk of harm (23, 24). In this
case, at least one relevant harm would be the inherent loss of
a healthy, functional, and erotogenic penile structure (25, 26),
amounting to approximately 30–50 cm2 of densely innervated,
elastic genital tissue in the adult organ (12, 27). Since this tis-
sue can be manipulated during sex and foreplay, resulting in a
range of concomitant sense perceptions (28), and since it protects
the sensitive head of the penis from abrasion as well as from dry-
ing out over time (25), its surgical removal entails a number of
arguably adverse outcomes, even if the circumcision is properly
performed (19).
To its discredit – and contrary to the practice of most non-
US-based national health organizations (10) – the CDC nowhere
in its proposed guidelines mentions, much less explores in any
detail, the actual anatomy or functions of the penile foreskin
(22). As Fleiss and Hodges (29) ask, “How can parents make a
rational decision about circumcision when they are told noth-
ing about the part that will be cut off?” (p. xii). For a point of
comparison, imagine a report by the CDC discussing the health
benefits of prophylactic mastectomy, in which the only implied
harms of the procedure were “surgical complications,” and in
which the anatomy and functions of the breasts were nowhere
described.
HARM
Most basically, the CDC’s approach runs counter to the conven-
tional bioethical (and legal) view that unnecessary surgeries, and
especially those that remove non-diseased, functional tissue from
an individual without his consent, are in and of themselves harm-
ful. As a California Appeals Court recently held [quoted in Ref.
(30)], “[I]t seems self-evident that unnecessary surgery is injuri-
ous and causes harm to a patient. Even if a surgery is executed
flawlessly, if the surgery were unnecessary, the surgery in and of
itself constitutes harm” (p. 469).
The only other potential harm that the CDC appears to have
entertained is the possibility of diminished sexual experience, find-
ing that: “Adult men who undergo circumcision generally report
minimal or no change in sexual satisfaction or function” [(1), p.
7]. However, the CDC’s appraisal of the literature on this point
is as superficial as it is selective3. As Bossio et al. (20) noted in
their recent review: “Adverse self-reported outcomes associated
with foreskin removal in adulthood include impaired erectile func-
tioning, orgasm difficulties, decreased masturbatory functioning
(loss in pleasure and increase in difficulty), an increase in penile
pain, a loss of penile sensitivity with age, and lower subjective rat-
ings of penile sensitivity” (p. 2853, internal references omitted).
While “other studies have found no significant differences in self-
reported sexual functioning following adult circumcision” (ibid.),
it must be remembered that a lack of statistical significance does
not entail a lack of underlying effect (31). For example, in one of
the studies cited by the CDC, “several questions were too vague
to capture possible differences between circumcised and not-yet
circumcised participants [such that] non-differential misclassifi-
cation of sexual [outcomes] probably favored the null hypothesis
of no difference, whether an association was truly present or not”
[(32), p. 313].
Finally, as noted earlier, the CDC ignores the fact that any sensa-
tion in the foreskin itself is necessarily eliminated by circumcision,
as are any sexually relevant (e.g., masturbatory) functions that
require its manipulation. As I have argued elsewhere: “To say that
circumcision has‘little or no effect’on sexual experience is to adopt
an extremely narrow conception of that term” [(19), p. 44]. More
generally, studies of adult male circumcision often lack adequate
3In the 61-page technical report which forms the basis for its proposed recommen-
dations, the CDC (65) dedicates a total of four sentences to the possible effects of
circumcision on sexual sensation, function, and/or satisfaction. Moreover, it fails
to reference, much less discuss, several well-known studies providing evidence of
negative effects of circumcision on sexuality [e.g., Ref. (71–74)], including some
that were available within the period of review. Instead, the CDC relies on a small
assortment of apparently randomly selected articles from the literature purporting
to show a lack of adverse outcomes, without citing any of the published critiques of
those studies. By contrast, a comprehensive, critical, and nuanced discussion of the
available evidence concerning the various sexual (and other) effects of circumcision
can be seen in the recent work of Bossio et al. (20). As these authors note, a previous
“systematic review” by Morris and Krieger (75), the first of whom is a long-time
advocate of neonatal circumcision (12, 76), is “not a meta-analysis, thus, no sta-
tistical analyses of the data have been performed; instead, the article presents the
authors’ interpretation of trends.” Problematically, however,“Morris and Krieger do
not report the results of this review collapsed across study quality. The conclusion
they draw – that circumcision has no impact on sexual functioning, sensitivity, or
sexual satisfaction – does not necessarily line up with the information presented in
their review, which is mixed” [(20), p. 2854].
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long-term follow-up, and assess only a limited range of sexual
outcome variables (19, 20).
RISK AND RISK PERCEPTION
In addition to its inadequate conception of risk, the CDC portrays
the risks that it does consider in a potentially misleading manner.
This is because it describes the “benefits of male circumcision [in
terms of] relative-risk reductions (e.g., a 50% reduction from a
2% risk of an STI to a 1% risk), whereas any associated harm is
expressed as an absolute risk (e.g., a 2–4% risk of adverse events)”
[(1), p. 2]. In other words, the purported benefits of circumcision
are described in figures whose values may be quite large despite
being derived from small absolute percentages [see, e.g., Ref. (12)],
whereas the potential harms are described in ‘small’ numbers (i.e.,
percentages expressing absolute risk). This may have the effect of
inflating the perceived likelihood and/or magnitude of the poten-
tial benefits of circumcision, and – by contrast – deflating the
perceived drawbacks and harms, especially in the minds of those
who are unversed in interpreting medical statistics [see, e.g., Ref.
(33, 34)]. Since this is likely to include the very individuals whom
the CDC suggests should undergo “counseling” about male cir-
cumcision, such differential risk-description poses a threat to the
ethical validity of obtaining their informed consent [see generally,
Ref. (35–37)]4.
This is not a trivial concern. As Hoffmann and Del Mar (38)
have shown, patients – in general – already tend to overestimate
the benefits of proposed medical interventions, and already tend
to underestimate the harms. Thus, unless patients (or parents)
clearly understand that their (or their child’s) absolute risk of, e.g.,
heterosexually acquired HIV infection in the United States is very
low – indeed zero before an age of sexual debut – the relative-
risk reduction figures presented by the CDC could give the wrong
impression.
HEALTH BENEFITS? TAKING INTO ACCOUNT GENDER AND
ETHICS
On the question of health benefits, suppose it could be shown
that removing the labia majora of infant girls reduced their risk
of acquiring a urinary tract infection (since there would be fewer
folds of moist genital tissue in which bacteria could find a home),
as well as, say, cancers of the vulva – or even HIV (39). It is not
biologically implausible. In fact, in countries in which female ‘cir-
cumcision’ is culturally normative, it is often said to confer a range
of such benefits, including “a lower risk of vaginal cancer . . . less
nervous anxiety, fewer infections from microbes gathering under
the hood of the clitoris, and protection against herpes and genital
ulcers” [(40), p. 258]. In addition, female ‘circumcision’ in such
4Related to this worry, it is important that patients (or parents) not mistake the
CDC’s recommendation about counseling regarding circumcision – a process whose
conclusion for any individual patient may very well be that it should not be done – for
a recommendation about circumcision generally, i.e., that it should be performed
as a routine procedure. But as patients (or parents) might reasonably ask, “Why
would the CDC both recommend that I be routinely counseled about the benefits
and risks of circumcision, as well as strongly suggest that the former outweigh the
latter, unless it ‘wanted’ me (or my son) to be circumcised?” Such mixed messaging
further reduces the possibility of obtaining (truly) informed consent, whether from
the patient or from his putative proxy.
countries is often described as ‘more hygienic’ as well as more
esthetically pleasing (41).
Now, it is not usually recognized that female ‘circumcision’ falls
on a spectrum; that some forms of it are less invasive than male
circumcision (including several forms that do not involve modi-
fication of the clitoris); and that it is sometimes done for reasons
other than (attempted) control of sexuality (42–47). Neverthe-
less, it is actually illegal in Western countries to conduct the very
research by which such ‘health benefits’ could be ‘discovered’ in the
first place. This is because non-therapeutic surgeries performed on
the genitals of healthy girls – no matter how slight, nor under what
material conditions – are deemed to be impermissible mutilations
in Western law (45).
Presumably, this is due to concerns about respect for sexual self-
determination, a desire to protect children’s (future) autonomy
[see Ref.(48–50)], and a recognition of their basic moral and legal
rights to bodily integrity and to security of the person (51–53).
Moreover, since there are more effective, but much less invasive,
ways of preventing and/or treating most of the diseases to which
the external female genitalia may sometimes fall prey – such as
the use of soap and water for simple hygiene, the adoption of safe
sex practices, and the administration of antibiotics, if required –
it seems reasonable to argue that pre-emptive surgery toward the
same ends would fail the test of proportionality (54).
Taken together, these considerations suggest that little girls
should be free to grow up with their genitals intact, and to decide,
at an age of understanding, whether they would like to undergo
permanent alterations to their ‘private parts,’ and if so, for what
reasons (and what kind). The same considerations apply equally
to boys [(40, 46, 50, 55–57); see also Ref. (58, 59) for further
discussion].
TIMING
With respect to timing, the CDC (1) states, “Neonatal male cir-
cumcision is, safer, [sic]5 and heals more rapidly than circumcision
performed on older boys [and] men, and is less expensive” (p. 4).
There are two points to consider here. First, as Svoboda and Van
Howe (60) have argued: “complications may certainly be better
documented for adults, who have the knowledge and wherewithal
to complain if something goes wrong; but there is no consistent
evidence that properly performed adult circumcision is actually
riskier.”6 Second, “It is true that it can be more costly, but only if
5It should be noted that the CDC background report is replete with typographical
errors such as this one, inaccurate referencing,and other signs of careless scholarship.
For example, Sandra Hassink – a CDC supporter and President of the AAP – notes
that the CDC literature review is out of date, that the CDC confuses adverse events
with remedies for adverse events, and that “some paragraphs are not well organized
or include non-sequiturs” [(77), np].
6Emphasis added. As they go on to state: “Only three studies have directly compared
the complication rates of infant and later circumcision. One found no difference;
another found a significantly greater rate following infant circumcision; and a third
found the opposite when using a Plastibell device” (np, internal refs omitted). The
issue of direct comparison is important. This is because the claim that infant circum-
cision has fewer risks compared to later (i.e., adult) circumcision is often grounded
in appeals to retrospective comparisons of different studies (or data sets), conducted
by different researchers, with results drawn from discordant populations. Thus they
do not adequately control for such variables as the skill of the practitioner, the
specific device(s) used, the sterility of the environment, and so on. For an in-depth
discussion, see one of the formal peer reviews of the CDC background materials (78).
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proper pain control is used: general anesthesia is contra-indicated
in infants, meaning that the surgery is performed either with
no pain control or with sub-optimal pain control, driving down
costs at the expense of humane treatment” [(60), np; see also Ref.
(61, 62)]7.
A further concern – again – has to do with the interpretation
of risk. According to even proponents of circumcision, such as
Brian Morris (63), the absolute likelihood of clinically significant,
non-resolvable surgical complications associated with the surgery
is low, regardless of the age at which it is performed. Thus, even
if one were to grant that there is a relative-risk reduction in the
incidence of adverse events – over and above the loss of erogenous
tissue – this consideration would not be morally decisive.
To see why this is the case, consider the hypothesis that any
number of surgeries might be (statistically) ‘safer’ if carried out in
the neonatal period. The prior question, however, is whether the
surgery itself is ethically sound. For example, imagine that it could
be shown that removing a child’s earlobes for non-therapeutic rea-
sons was ‘less risky’ if it were done to an infant. Nevertheless, from
a moral perspective, such an intervention would be seen as clearly
impermissible (52, 64).
To its credit, the CDC (65) seems to recognize such concerns,
although it does not discuss them in any detail in its actual (pro-
posed) recommendations. Instead, in a less accessible background
technical report, it states that: “Delaying male circumcision until
adolescence or adulthood obviates concerns about violation of
autonomy” (p. 39), and therefore any “disadvantages associated
with [such a deferral] would be ethically compensated to some
extent by the respect for the [bodily] integrity and autonomy of
the individual” (pp. 39–40).
CONCLUSION
As Murphy (66) has argued: “Biomedical research and its social
applications are almost always worthy of sustained critical
scrutiny” (p. 11). In the case of circumcision, in particular –
originally a ritual practice with a long history of being dubiously
medicalized (67) – it is important to be especially skeptical (12).
At the end of the day, it is not altogether clear that a minor reduc-
tion in the absolute risk of certain infections or diseases – whose
prevalence in developed nations is generally low, and whose occur-
rence can typically be avoided by other, less injurious means8 – is
7As Bellieni et al. [(62), p. 1] note, “no procedure has been found to definitively
eliminate pain; the gold standard procedure to make MC totally painfree has not yet
been established.”
8As Kluge (82) asks, “Is it ethically appropriate to perform circumcisions because
there is some statistical evidence that a potentially curable disease with a low inci-
dence rate may be prevented by surgery, even though the disease also occurs in
people who have undergone the surgery and the incidence rate of the disease in
countries where the surgery is not routinely performed is similar to that in coun-
tries where it is? If the answer to this question is Yes, then the same underlying
principle should be applied to all similar cases: whenever there is statistical evidence
that a potentially curable disease or condition with a low incidence rate could be
prevented by surgery, but the evidence also indicates that the incidence rate is the
same (or similar) in other countries where the surgery is not routinely performed,
we should still perform the surgery in every person in whom the disease or condition
might develop. All sorts of medical conditions would be implicated. I suspect that
we would be operating nonstop on just about every part of the human body if we
took this stance. I shudder to think of the cost – and the implications for public
health” (p. 1452).
worth the ‘trade-off ’ of losing a part of one’s penis. What is cer-
tain, however, is that the answer to this question is likely to be
highly subjective, and to depend upon numerous, unpredictable,
and ultimately personal factors [see Ref. (24)]. Therefore, it should
be up to the affected individual himself (or indeed herself, in
analogous circumstances) to decide about permanent genital-
modification surgeries at such a time as he or she can meaningfully
factor in his or her own preferences and values [see Ref. (46, 48,
51)]9. Circumcision before an age of consent is not a desirable
health-promotion strategy, given more effective, and less ethically
problematic, alternatives.
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